1. Yadav VN, Zamler D, Baker GJ, Kadiyala P, Erdreich-Epstein A, DeCarvalho AC,
Mikkelsen T, Castro MG, Lowenstein PR. CXCR4 increases in-vivo glioma
perivascular invasion, and reduces radiation induced apoptosis: A genetic
knockdown study. Oncotarget. 2016; PubMed [journal] PMID: 27863376

2. Baker GJ, Chockley P, Zamler D, Castro MG, Lowenstein PR. Natural killer cells
require monocytic Gr-1(+)/CD11b(+) myeloid cells to eradicate orthotopically
engrafted glioma cells. Oncoimmunology. 2016; 5(6):e1163461. PubMed [journal]
PMID: 27471637, PMCID: PMC4938363

3. Kamran N, Candolfi M, Baker GJ, Ayala MM, Dzaman M, Lowenstein PR, Castro MG.
Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System
Neoplasms. Methods in molecular biology (Clifton, N.J.). 2016; 1382:467-82.
NIHMSID: NIHMS742494 PubMed [journal] PMID: 26611605, PMCID: PMC4677484

4. Baker GJ, Castro MG, Lowenstein PR. Isolation and Flow Cytometric Analysis of
Glioma-infiltrating Peripheral Blood Mononuclear Cells. Journal of visualized
experiments : JoVE. 2015; (105). NIHMSID: NIHMS753506 PubMed [journal] PMID:
26650233, PMCID: PMC4692754

5. Calinescu AA, Kamran N, Baker G, Mineharu Y, Lowenstein PR, Castro MG. Overview
of current immunotherapeutic strategies for glioma. Immunotherapy. 2015;
7(10):1073-104. NIHMSID: NIHMS741875 PubMed [journal] PMID: 26598957, PMCID:
PMC4681396

6. Lowenstein PR, Baker GJ, Castro MG. Cracking the glioma-NK inhibitory code:
toward successful innate immunotherapy. Oncoimmunology. 2014; 3(11):e965573.
PubMed [journal] PMID: 25941594, PMCID: PMC4292565

7. Castro MG, Baker GJ, Lowenstein PR. Blocking immunosuppressive checkpoints for
glioma therapy: the more the Merrier! Clinical cancer research : an official
journal of the American Association for Cancer Research. 2014; 20(20):5147-9.
NIHMSID: NIHMS655713 PubMed [journal] PMID: 24879798, PMCID: PMC4330468

8. Baker GJ, Chockley P, Yadav VN, Doherty R, Ritt M, Sivaramakrishnan S, Castro MG,
Lowenstein PR. Natural killer cells eradicate galectin-1-deficient glioma in the
absence of adaptive immunity. Cancer research. 2014; 74(18):5079-90. NIHMSID:
NIHMS615537 PubMed [journal] PMID: 25038230, PMCID: PMC4184887

9. Baker GJ, Yadav VN, Motsch S, Koschmann C, Calinescu AA, Mineharu Y,
Camelo-Piragua SI, Orringer D, Bannykh S, Nichols WS, deCarvalho AC, Mikkelsen T,
Castro MG, Lowenstein PR. Mechanisms of glioma formation: iterative perivascular
glioma growth and invasion leads to tumor progression, VEGF-independent
vascularization, and resistance to antiangiogenic therapy. Neoplasia (New York,
N.Y.). 2014; 16(7):543-61. PubMed [journal] PMID: 25117977, PMCID: PMC4198934

10. Lynes J, Wibowo M, Koschmann C, Baker GJ, Saxena V, Muhammad AK, Bondale N, Klein
J, Assi H, Lieberman AP, Castro MG, Lowenstein PR. Lentiviral-induced high-grade
gliomas in rats: the effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H.
Neurotherapeutics : the journal of the American Society for Experimental
NeuroTherapeutics. 2014; 11(3):623-35. PubMed [journal] PMID: 24752661, PMCID:
PMC4121445

11. Assi H, Candolfi M, Baker G, Mineharu Y, Lowenstein PR, Castro MG. Gene therapy
for brain tumors: basic developments and clinical implementation. Neuroscience
letters. 2012; 527(2):71-7. NIHMSID: NIHMS401218 PubMed [journal] PMID: 22906921,
PMCID: PMC3462660

12. Candolfi M, Kroeger KM, Xiong W, Liu C, Puntel M, Yagiz K, Muhammad AG, Mineharu
Y, Foulad D, Wibowo M, Assi H, Baker GJ, Lowenstein PR, Castro MG. Targeted
toxins for glioblastoma multiforme: pre-clinical studies and clinical
implementation. Anti-cancer agents in medicinal chemistry. 2011; 11(8):729-38.
NIHMSID: NIHMS336555 PubMed [journal] PMID: 21707497, PMCID: PMC3364590

13. Kroeger KM, Muhammad AK, Baker GJ, Assi H, Wibowo MK, Xiong W, Yagiz K, Candolfi
M, Lowenstein PR, Castro MG. Gene therapy and virotherapy: novel therapeutic
approaches for brain tumors. Discovery medicine. 2010; 10(53):293-304. NIHMSID:
NIHMS250312 PubMed [journal] PMID: 21034670, PMCID: PMC3059086

14. Muhammad AK, Puntel M, Candolfi M, Salem A, Yagiz K, Farrokhi C, Kroeger KM,
Xiong W, Curtin JF, Liu C, Lawrence K, Bondale NS, Lerner J, Baker GJ, Foulad D,
Pechnick RN, Palmer D, Ng P, Lowenstein PR, Castro MG. Study of the efficacy,
biodistribution, and safety profile of therapeutic gutless adenovirus vectors as
a prelude to a phase I clinical trial for glioblastoma. Clinical pharmacology and
therapeutics. 2010; 88(2):204-13. NIHMSID: NIHMS201148 PubMed [journal] PMID:
20164833, PMCID: PMC2908190

15. Meneni SR, D'Mello R, Norigian G, Baker G, Gao L, Chiarelli MP, Cho BP. Sequence
effects of aminofluorene-modified DNA duplexes: thermodynamic and circular
dichroism properties. Nucleic acids research. 2006; 34(2):755-63. PubMed
[journal] PMID: 16449208, PMCID: PMC1356535